Showing results (1271-1280 of 2,466) with videos related to
Sort By:
Pageof 247
Therapie|June 24, 2006
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]Jean-Louis Montastruc, Agnès Sommet, Pascale Olivier, et al.Therapie|June 24, 2006
[A review of potential signals generated by an automated method on 3324 pharmacovigilance case reports]Cédric Bousquet, Chit Sadakhom, Christine Le Beller, et al.Therapie|August 5, 2006
Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotensionKarine Desboeuf, Maryse Grau, Françoise Riche, et al.Therapie|August 5, 2006
[Treatment of bronchial superinfections: data related to stability of antibiotics in portable pumps]Pascale De Calbiac, Fabien Lamoureux, Xavier Pourrat, et al.Therapie|August 5, 2006
[Analysis of antiretroviral drugs-induced adverse effects]Magalie Baudrant, Haleh Bagheri, Lise Cuzin, et al.Therapie|September 1, 1991
["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases]A Castot, I Bidault, I Bournerias, et al.Therapie|September 1, 1991
[Bismuth revisited in Helicobacter pylori gastro-duodenal infection]F Caron, B RouveixTherapie|November 28, 2006
Protocolisation, use and development of anti-cancer drugs in the context of T2A (case-mix based payment system) set-upAnne Mathieu-Boué, Pierre Demolis, Jean-François BergmannTherapie|November 28, 2006
Public-private partnership models in France and in EuropeJacques Demotes-Mainard, Emmanuel Canet, Lionel SegardTherapie|November 28, 2006
[What is the place of beta-adrenergic blockade therapy in coronary syndromes in the modern management era?]Pierre-Vladimir Ennezat, Jean-Luc Auffray, Clément Charbonnel, et al.Pageof 247